Market Analysis - Integrative Biology 2017
The UK is one of the best places in the world for life sciences, on a par with premier life science destinations such as Boston, San Francisco, San Diego and Singapore. The 4 of the top 10 universities in the world, 19 of the top 100 universities, one of the world’s 3 major financial centers, a stable of quality service providers, world class charitable supporters of the industry and a rich heritage of globally recognized medical research. There are nearly 5,633 life sciences companies in the UK employing an estimated 222,000 people and generates a combined estimated turnover of £60.7 billion. The industry sells into a global industry with current total market values of US$956bn for pharmaceutical and biologics, US$349bn for medical technology and US$50bn for the rapidly growing industrial biotechnology market. There are significant levels of health life sciences employment. This breaks down into: 107,000 employed in the biopharmaceutical sector and service and supply chain in 1,948 companies, generating £39.7 billion turnover; 115,000 employed in the medical technology sector and service and supply chain in 3,685 companies, generating £21 billion turnover. Two thirds of employment is outside of London and the South-East with significant concentrations in the East of England (15%, almost 34,000 people) and North-West (12%, almost 26,000 people). It shows that the UK is second only to the US in terms of life science Foreign Direct Investment projects along with the UK’s relative strength in the academic base and clinical research landscape. Combined with the strength of the health life sciences supply chain, these factors are driving investment, growth and employment across the country.
Adjusting for these methodology changes overall jobs growth in the sector is estimated to be 2.9% and overall revenue growth is estimated to be 0.8%. The life science industry is global and 42% of employment is at UK owned companies and 49% of employment is at overseas-owned companies and 10% where the ownership location is unknown.
UK life science companies continue to tackle long-term health challenges such as cancer and antimicrobial resistance, and in addition to this many companies are using bioscience to address a range of issues including environmental challenges and chemical production. This predominantly healthcare manifesto also recognizes the growing importance of these new applications.
London’s life sciences sector is a shining jewel and a cornerstone of the city’s economy. With a rich history of achievements and medical firsts, the sector employs more than 21,000 in private sector industry, hospitals and research facilities including more than 2,000 researchers. The sector impact is in the manner: $720 Million Indirect benefits/ Economic Spinoffs; 780 number of principal researchers and 19 research institutes. The Major Biotech Companies in London are: Albert Browne Ltd, Parexel Informatics, Alcon Laboratories (UK) Ltd, Baxter Healthcare Ltd, Galderma Laboratories, Agilent Technologies, Abbott Laboratories, and Bayer Healthcare.
London's biotech universities and their spin out companies are Gene Expression Technologies, Photobiotic, Biogenic, Spirogen, Genexsyn, Nervation, Inpharmatica, Immune Regulation Ltd, Cerestem, and MedPharm, Immexis, and Antisoma plc.
London is the capital and most populous city of England, United Kingdom and the European Union. With an estimated 2015 population of 8.63 million within a land area of 1,572 km², London is a leading global city, with strengths in the research and development, arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, tourism, and transport all contributing to its prominence. It is one of the world's leading financial centers and has the fifth-or sixth-largest metropolitan area GDP in the world depending on measurement.
London is a world cultural capital. It is the world's most-visited city as measured by international arrivals and has the world's largest city airport system measured by passenger traffic. London's 43 universities form the largest concentration of higher education institutes in Europe.
List of major societies in UK:
Royal Society of Biology
Royal Society of Chemistry
BBSRC (Biotechnology and Biological Sciences Research Council)
The Oxford University Society
British Society for Cell Biology
Royal Society of Edinburgh
Royal Society of Medicine
Astrobiology Society of Britain
British Medical Association
British Society for the History of Medicine
The Mammal Society
Royal Institute of Public Health
Society for Experimental Biology
Zoological Society of London
List of universities and institutes in London:
The Francis Crick Institute, London
University College London
Imperial College London
University of East London
Kingston University London
University of Westminster
Birkbeck, University of London
Goldsmiths, University of London
King's College London
Queen Mary University of London
St George's, University of London
The major universities and institutes in UK are:
University of Leeds, University of Leicester, Leeds Trinity University, University of Glasgow, University of Exeter, University of Essex, University of Edinburgh, University of Dundee, Durham University, Cardiff University, University of Chester, University of Bristol, University of Birmingham, University of Bath, University of Cambridge, Anglia Ruskin University, Aston University, University of Bradford, University of East Anglia, University of Liverpool, Loughborough University, University of Nottingham, University of Reading, Queen's University Belfast, University of Sheffield, University of Southampton, University of Sussex, University of Warwick and University of York.
The major Biotech Companies in UK are:
GSK (Stevenage), Martindale Pharmaceuticals Ltd (Brentford), Nova Bio-pharma Holdings Limited, Oxoid Ltd, Omega Pharma Ltd, Quintiles Ltd (Guys Research Centre), Sauflon Pharmaceuticals Limited, Immuno Diagnostic Systems Ltd, Merck Serono Ltd, Quest Diagnostics Ltd, and Fujifilm Diosynth Biotech UK Ltd.
We are glad to announce the 5th International Conference on Integrative Biology to be held in London, UK from June 19-21, 2017 organized by Conference Series LLC, UK in collaboration with generous support and cooperation from enthusiastic academicians and editorial Board Members.
Integrative Biology 2017 offers a premier forum to inspire collaboration among biologists and to share trans-disciplinary integrativethinking to unravel the underlying cellular and molecular mechanisms in health, disease and medicine. The theme of the conference is “Explore interdisciplinary approaches of Cellular and Molecular Life Sciences” and topics for discussion are Cellular Biology, Molecular Biology, Molecular Genetics, Molecular Cell, Cellular DNA Studies, Cellular Dynamics, Biomolecular Structure and Function, Cell Cycle, Cellular Signalling, Cell Death, Cell Growth & Differentiation, Cell Regeneration, Stem Cell Biology, Gene Expression and Regulation, Cell Biology of Metabolic Diseases, Cell Biomechanics and Regulations, Epigenetics, Molecular Mechanisms of Diseases,
Cellular Movement and Cell Motility, Molecular Structure & Behavior of Membrane Proteins, DNA Damage and Repair.
As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.